| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,922 |
9,927 |
$524K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,535 |
2,775 |
$188K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,526 |
2,463 |
$99K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,451 |
1,343 |
$36K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,846 |
1,936 |
$35K |
| 99199 |
Unlisted special service, procedure or report |
10,838 |
10,442 |
$32K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,807 |
2,045 |
$29K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
371 |
265 |
$23K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
617 |
412 |
$9K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
17 |
12 |
$5K |
| 81003 |
|
1,291 |
1,073 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
15 |
13 |
$2K |
| 99051 |
|
49 |
48 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
254 |
193 |
$555.61 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
106 |
70 |
$312.79 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
778 |
570 |
$269.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
995 |
563 |
$130.43 |
| 81002 |
|
36 |
34 |
$91.35 |
| 36415 |
Collection of venous blood by venipuncture |
25 |
13 |
$31.69 |